An observational study in Cervical Cancer, sponsored by Fujian Maternity and Child Health Hospital. Completed. Open to female participants aged 25 Years to 70 Years. Per ClinicalTrials.gov, last updated 2023-09-13.
Sponsored by Fujian Maternity and Child Health Hospital · Observational
The lymph node status is difficult to be assessed preoperatively, this study aimed to develop a scoring system for predicting the risk of LNM in cervical cancer patients before operation.
Lymph nodes metastasis (LNM) was proved to be a critical risk factor related to the survival to cervical cancer survival. However, preoperative pelvic magnetic resonance imaging (MR) or computed tomography (CT) tests are less sensitive to assess the risk of lymph node metastasis. PET-CT is too expensive and radiative to be widely used in clinical practice. A model was constructed based on clinical indicators to predict lymph node metastasis preoperatively, providing a reference for clinical treatment.
1,881 studies on the registry are indexed under Uterine Cervical Neoplasms; 567 are open to participants now.
This study's enrollment of 426 is above the median of 220 across 419 observational studies indexed under Uterine Cervical Neoplasms.
Browse Uterine Cervical Neoplasms studies →Fujian Maternity and Child Health Hospital is the lead sponsor of 14 studies on the registry; 10 are open to participants now.
Counted across the registry records on this site, refreshed daily.
A total of 426 patients with cervical cancer who underwent radical resection in China were recruited
Exclusion Criteria:
Patients confirmed cervical cancer were undergone radical hysterectomy with pelvic lymphadenectomy
Overall survival
death or loss of follow-up
Time frame: 60 months
Risk factors influenced LNM
A multivariable logistic regression analysis was used to analysis the independent factors that contribute to LNM.
Time frame: 60 months
The accuracy of the model
The AUC curve was used to assess the discrimination of the scoring system. The comparison between predicted (mean ± SD) and observed rates of LNM was used to test the calibration. The Hosmer-Lemeshow test evaluated the model fit.
Time frame: 60 months
No study locations are listed for this record.
Plan to share: Undecided
No publications or documents are linked to this record.
This study is completed, as verified in Sep 2023. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Fujian Maternity and Child Health Hospital